|
|
|
|
|
|
By Ed Silverman
Joe Raedle/Getty Images
“We’ve got to do something,” said Tom Leek, the Republican lawmaker who introduced the House version of the legislation in Florida.
Read More
|
|
By Matthew Herper
APStock
The drug reduced low-density-lipoprotein cholesterol by more than 17 percent in 12 weeks and sustained those results for a full year, according to new data.
Read More
|
|
By Adam Feuerstein
APStock
Dermira believes new, positive data suggest its lebrikizumab could be equally or more effective than Dupixent in atopic dermatitis.
Read More
|
|
Sponsor content by STAT Expert Advantage
Last chance to join this week’s conference call: Digging into Amarin’s REDUCE-IT data
Join STAT senior writers Matt Herper and Adam Feuerstein, and Dr. Michael Davidson, Professor of Medicine and Director of the Lipid Clinic at the University of Chicago for our March 20 STAT Expert Advantage conference call: Digging into Amarin’s REDUCE-IT data. They’ll discuss the new Vascepa data being presented at today’s meeting of the American College of Cardiology, its potential impact for patients, and the outlook for Amarin’s business. Become a member of STAT Expert Advantage today to access this fully compliant call — and others like it throughout the year.
|
|
By Matthew Herper
Amarin
With Vascepa, first heart problems were cut by 25 percent, second ones by 32 percent, third events by 31 percent, and fourth events by 48 percent.
Read More
|
|
By Ed Silverman
Adobe
The proposed law would allow the government to determine the price of a patented medicine based on whether the buyers have “economic accessibility.”
Read More
|
|
By Matthew Herper
Mel Evans/AP
Apple is teaming with J&J to a conduct a study of 180,000 people over the age of 65 to get a better understanding of the Apple Watch's impact on health.
Read More
|
|
